Search results
Results From The WOW.Com Content Network
In June 2022, lab space inventory in Greater Boston was estimated to have more than doubled over the preceding decade from 18.6 million square feet in 2012 to 41 million square feet in 2022 (with the second largest market of lab space in the country in the San Francisco Bay Area trailing Greater Boston by 10 million square feet), and lab space ...
Boston Scientific, which makes pacemakers, stents and catheters, will pay $71 in cash per share, representing a 23.3% premium to the Axonics' last close. Axonics' products, such as Axonics R20 and ...
Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...
Boston Scientific's device, which it plans to launch in the coming months, is a balloon catheter coated with a drug called paclitaxel and is designed to transfer the drug to the vessel wall to ...
An investigation showed that Boston's device, Obsidio Embolic, when used with a specific technique posed a higher risk of bowel ischemia during procedures to stop gastrointestinal (GI) bleeding ...
Boston University boasts that there is a waiting list for researchers wanting to conduct research in the building. [2] The edifice was constructed out of three existing industrial buildings in 1983 when John Silber was Boston University's president. [3] [4] The building's modern atrium was originally a spacing between two of the original buildings.
Boston Scientific forecast a full-year profit on Wednesday that was largely ahead of analysts' estimates and said the U.S. health regulator has approved its heart device, sending the company's ...
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. [2] Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices.